Cargando…
Exposure to alirocumab during the first trimester of pregnancy: A case report
BACKGROUND: Familial hypercholesterolemia can be efficiently treated with combined lipid‐lowering drugs. Lipid‐lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful plans can be precipitated due to unexpected pregna...
Autores principales: | Vuignier, Yann, Beaud, Floriane, Kosinski, Christophe, Panchaud, Alice, Lebon, Sébastien, Baud, David, Kissling, Sébastien, Collet, Tinh‐Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453706/ https://www.ncbi.nlm.nih.gov/pubmed/34105316 http://dx.doi.org/10.1002/bdr2.1930 |
Ejemplares similares
-
Risk of congenital malformation following first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort
por: Favre, Guillaume, et al.
Publicado: (2023) -
Pregnancy Outcome after Varenicline Exposure in the First Trimester
por: Kaplan, Yusuf Cem, et al.
Publicado: (2014) -
Parathyroidectomy in First Trimester of Pregnancy
por: Sharma, Sonia G, et al.
Publicado: (2020) -
Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
por: Mosha, Dominic, et al.
Publicado: (2014) -
An international registry for emergent pathogens and pregnancy
por: Panchaud, Alice, et al.
Publicado: (2020)